Call to arrange a consultation
+1 416 777 0888

Carol Hitchman

Partner

Carol has been involved in cases relating to basic compound patents, formulation patents and use patents and has been involved extensively in litigation relating to trademarks for the appearance of pharmaceuticals. Carol has written numerous papers and given presentations for the Intellectual Property Institute of Canada (IPIC), the Law Society of Upper Canada and the Canadian Bar Association, including presentations to Federal Court judges and prothonotaries. Carol has taught Patent Agent Tutorials for IPIC as well as the IPIC’s McGill Patents course.

Education

  • B.A., University of Toronto
  • LL.B., University of Toronto

Bar Admission

  • Ontario, 1984

Carol Hitchman

Recent Cases

Action under the new Patented Medicines (Notice of Compliance) Regulations relating  to Patent No. 2,752,550 (pomalidomide)

Action under the new Patented Medicines (Notice of Compliance) Regulations relating  to Patent No. 2,794,060 (pomalidomide)

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,791,171 (apixaban)

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,461,202 (apixaban)

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,344,318 and 2,743,326 (daptomycin)

Patent infringement regarding Patent No. 2,743,326 (daptomycin)

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,507,002 and 2,496,780 (silodosin)

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,823,159, 2,634,310 and 2,547,113 (rivaroxaban)

CIRA domain name dispute relating to the domain name STRIPMEISTER.CA

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding  Patent Nos. 2,823,159, 2,634,310 and 2,547,113 (rivaroxaban)

Application under the old Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,477,301, 2,688,709, 2,476,983, 2,688,694, 2,537,092, 2,687,927, 2,688,695, 2,741,575, 2,688,708, 2,687,924 and 2,741,412 (lenalidomide)

Application under s. 18.1 of the old Patented Medicines (Notice of Compliance) Regulations  regarding Patent No. 2,586,023 (sevelamer)

Action under the Trademarks Act and the Competition Act regarding Registration Nos. TMA580,557 (ENERGIZER MAX), 157,162 (ENERGIZER) and 740,338 (ENERGIZER)

Patent infringement case regarding Patent No. 2,355,347 (quinapril)

Patent infringement case regarding Patent No. 1,336,777 (clopidogrel).

Patent infringement case regarding Patent No. 1,336,777 (clopidogrel).

More people

Interested in joining the team?

We are always on the lookout for talented individuals.

View Careers